Kuala Lumpur, June 28: DC Healthcare Holdings Berhad, an established aesthetic medical services provider specializing in the provision of non-invasive and minimally invasive procedures, launched the prospectus today in conjunction with the Group’s initial public offering (“IPO”) on the ACE Market of Bursa Malaysia Securities Berhad (“Bursa Securities”).
The IPO will raise RM49.81 million via the issuance of 199.26 million new shares at the IPO price of RM0.25 per share to fund DC Healthcare’s growth plans as well as working capital and repayment of borrowings. The proceeds will be used in the following manner:
- RM9.44 million to establish aesthetic medical clinics
- RM13.12 million to purchase medical machinery and equipment
- RM6.24 million to repay borrowings
- RM17.01 million for working capital, including staff salaries as well as medical supplies and consumables
- RM4.00 million for estimated listing expenses
Managing Director of DC Healthcare, Dr. Chong Tze Sheng said, “DC Healthcare’s expansion plan is based on demand for aesthetic medical services as people are becoming more aware of skin health, as well as wanting to look and feel good about themselves, especially in the long run. It is projected that aesthetic medical services and general medical services related to skin disease will increase due to people having more disposable income for discretionary spending and becoming better educated on skin conditions.”
Danny Wong, Deputy Head of Corporate Finance, of M&A Securities Sdn Bhd said, “The Malaysian market for aesthetic medical services will continue to grow supported by demand as incomes rise and populations age. This will be helped along by the increased consumerism and growing influence of social media removing the stigma of aesthetic medical procedures. With the growing acceptance of such treatments, the domestic aesthetic medical services market is projected to have a compound annual growth rate of 18.8% from 2021 to 2027 valuing the total market at RM1.03 billion.”
DC Healthcare – or famously known ‘Dr. Chong Clinic’ or ‘Klinik Dr. Chong’ – provides aesthetic services, general medical services, and the sale of skincare products. DC Healthcare currently has 13 clinics and 10 LCP Certified Aesthetic Physicians, assisted by 29 resident medical doctors in the central and southern regions of Peninsular Malaysia namely in Negeri Sembilan, Selangor, Johor, and Kuala Lumpur.
For the financial year ended 31 December 2022 (“FYE2022”), the Group recorded revenue of RM51.96 million compared with RM25.48 million in FYE2021 with a net profit margin of 18.40 per cent and 18.06 per cent respectively.
Aesthetic services contributed 89.96% to total revenue for FYE2022 and 84.88 per cent in FYE2021, compared to general medical services which contributed 10.04 percent in FYE2022 and 15.12 per cent in FYE2021.
In addition, for the financial year ended 31 December 2020 (“FYE2020”) and 31 December 2019 (“FYE2019”), DC Healthcare registered revenue RM14.45 million and RM12.21 million respectively. Aesthetic services contributed 89.80 per cent in FYE2019 and 87.50 per cent in FYE2020 to the total revenue, while general medical services contributed 10.20 per cent in FYE2019 and 12.50 per cent in FYE2020.
Welcome to dailystraits.com. Please send all interview requests and press releases to email@example.com.